Association between the −11377 C/G and −11391 G/A polymorphisms of adiponectin gene and adiponectin levels with susceptibility to type 1 and type 2 diabetes mellitus in population from the west of Iran, correlation with lipid profile
- 11 September 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (3) , 3574-3582
Abstract
Adipose tissue, an endocrine organ, secretes bioactive factors including adiponectin. Adiponectin is a protein hormone that enhances insulin sensitivity through increased fatty acid oxidation and inhibition of hepatic glucose production. We assessed the association of the adiponectin promoter region polymorphisms −11391 G/A and −11377 C/G with susceptibility to type 1 (T1DM) and type 2 (T2DM) diabetes mellitus in the population of west Iran. Also, we investigated the effect of adiponectin level and lipid profile on T1DM and T2DM development. In this case‐control study, we recruited 189 patients with diabetes (100 T2DM and 89 T1DM) and 161 sex and age‐matched unrelated healthy controls. Adiponectin mutations were detected by polymerase chain reaction‐restriction fragment length polymorphism (PCR‐RFLP), and the protein level was measured by the enzyme‐linked immunosorbent assay. Other biochemical parameters were determined by routine laboratory methods. The G allele of adiponectin gene at −11377 position (C/G) significantly increased the risk of T1DM. With respect to genotype models, codominant (2.97 times), dominant (3.6‐fold), and over‐codominant (2.9‐fold) patients with T1DM who carried −11377 C > G single‐nucleotide polymorphisms were significantly susceptible to the development of the disease. A significantly higher level of adiponectin in T1DM was oberved compared with the control group. In contrast, patients with T2DM had lower adiponectin levels compared with healthy controls. The genotype distributions of −11391 G/A polymorphisms were the same for patients with diabetes and control groups. The presence of G allele at −11377 C/G adiponectin gene significantly increased serum adiponectin level and may be a risk factor for T1DM susceptibility among the western Iranian population.Keywords
Funding Information
- Kermanshah University of Medical Sciences (924304)
This publication has 27 references indexed in Scilit:
- Increase in the Incidence of Diabetes and Its ImplicationsNew England Journal of Medicine, 2017
- Adipokines as Drug Targets in Diabetes and Underlying DisturbancesJournal of Diabetes Research, 2015
- Effect of adiponectin gene polymorphisms on waist circumference in patients with diabetesJournal of Diabetes & Metabolic Disorders, 2012
- Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytesMetabolism, 2008
- Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention ProgramDiabetes, 2008
- Adipokines and Risk of Type 2 Diabetes in Older MenDiabetes Care, 2007
- Reversal of Obesity-Related Hypoadiponectinemia by Lifestyle Intervention: A Controlled, Randomized Study in Obese AdolescentsThe Journal of Clinical Endocrinology & Metabolism, 2005
- Adiponectin: action, regulation and association to insulin sensitivityObesity Reviews, 2005
- Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030Diabetes Care, 2004
- Is insulin resistance the principal cause of type 2 diabetes?Diabetes, Obesity and Metabolism, 1999